1. Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells
   Dawei Li et al, 2016, Oncology Letters CrossRef
2. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter
   Nicole A. Seebacher et al, 2016, Journal of Biological Chemistry CrossRef
3. Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies
   Chao Pan et al, 2025, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
4. MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks
   Wenbin Li et al, 2015, Drug Metabolism Reviews CrossRef
5. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
   Hassan Dianat-Moghadam et al, 2018, Journal of Controlled Release CrossRef
6. Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-cancer Drug Testing in 3D Culture
   Stephanie Lemmo et al, 2014, Cellular and Molecular Bioengineering CrossRef
7. Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin
   Ashley M. Laughney et al, 2014, Science Translational Medicine CrossRef
8. HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer
   YI SUN et al, 2016, Oncology Reports CrossRef
9. Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
   Farzaneh Kordbacheh et al, 2021, Cancers CrossRef
10. Relative quantitative expression of hypoxia-inducible factor-1α, −2α and −3α, and vascular endothelial growth factor A in laryngeal carcinoma
    TODOR MIROSLAVOV POPOV et al, 2015, Oncology Letters CrossRef
11. A review of the last decade: pancreatic cancer and type 2 diabetes
    Jiaqi Wu et al, 2024, Archives of Physiology and Biochemistry CrossRef
12. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
    Katarzyna Starska et al, 2015, Tumor Biology CrossRef
13. MDR1 not CYP3A4 gene expression is the predominant mechanism of innate drug resistance in pediatric soft tissue sarcoma patients
    Dora Molina-Ortiz et al, 2018, Cancer Biomarkers CrossRef
14. Molecular and cellular paradigms of multidrug resistance in cancer
    Foram U. Vaidya et al, 2022, Cancer Reports CrossRef
15. Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT
    Jianhong Zuo et al, 2016, Medical Oncology CrossRef
16. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy
    Anita Mangia et al, 2015, Cancer Biology & Therapy CrossRef
17. β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance
    Maura Calvani et al, 2020, International Journal of Molecular Sciences CrossRef
18. Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
    Jiangjun Cao et al, 2023, MedComm CrossRef
19. Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches
    Namita Mahadik et al, 2022, WIREs Nanomedicine and Nanobiotechnology CrossRef
20. Dissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroids
    Mohammad Azharuddin et al, 2019, Scientific Reports CrossRef
21. β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo
    Luca Filippi et al, 2022, Medicinal Research Reviews CrossRef
22. The multi-factorial nature of clinical multidrug resistance in cancer
    Yehuda G. Assaraf et al, 2019, Drug Resistance Updates CrossRef
23. Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer
    Xiangli Bai et al, 2024, European Journal of Pharmacology CrossRef
24. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
    Nuray Erin et al, 2020, Drug Resistance Updates CrossRef
25. Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
    Zaira Rehman et al, 2019, PeerJ CrossRef
26. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
    Dimas Carolina Belisario et al, 2020, Cells CrossRef
27. Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance
    Muhammad Affan Elahi et al, 2025, International Journal of Molecular Sciences CrossRef
28. COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models
    Hyeong Seok Kim et al, 2018, Biomaterials CrossRef